Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company's website.
http://www.businesswire.com/news/topix/20130925005361/en
http://www.businesswire.com/news/topix/20130925005361/en
No comments:
Post a Comment